Impaired gastric emptying

1. Semaglutide is associated with impaired gastric emptying in humans (2,200 reports; 5.03%).

   “Impaired gastric emptying (n = 2,200; 5.03%) showed a markedly elevated reporting signal.”

   HumansAdverse event reports listing semaglutide as the primary suspected drug

   Characterizing the Adverse Event Profile of Semaglutide: A Comprehensive U.S. Food and Drug Administration Adverse Event Reporting System-Based Pharmacovigilance Study

   Clinical nutrition ESPEN·12 Oct 2026

More on Semaglutide